Skip to content

Innoviva, Inc. INVA Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

Savara logo
SavaraSVRA
$500-71.4%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: Innoviva, Inc.’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s proceeds from warrant exercises?
Innoviva, Inc. (INVA) reported proceeds from warrant exercises of $10.7M in Q3 2025.
What does proceeds from warrant exercises mean?
This metric represents the cash inflows received by the company when holders of warrants exercise their right to purchase common stock at a predetermined price. It reflects a source of non-dilutive or pre-planned equity financing that strengthens the company's cash position. Investors monitor this to assess the potential impact on share count dilution and the company's ability to raise capital through existing financial instruments.